Brief: Ipsen FY Adjusted EPS EUR 10.27 Vs. IBES Estimate EUR 9.5
Feb 13 (Reuters) - Ipsen FY EPS EUR 4.15. * FY revenue EUR 3,400.6 million vs. IBES estimate EUR 3,487 million * FY EBIT margin 14.6% * FY adjusted EBIT EUR 1,109.4 million vs. IBES estimate EUR 1,016 million * FY EBIT EUR 496.7 million * FY adjusted EBIT margin 32.6%
Recent news on Ipsen SA
See all newsHealth Rounds: New blood test matches gold standard for liver disease diagnosis
Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC
Brief: Charles River Laboratories International Virtual Control Group To Be Used In Glp Study For Ipsen
Pharming shares rise after preliminary Q3 revenue beat
France's Ipsen Q3 sales rise 28% driven by core portfolio